2019-NCoV IgM / IgG Detection Kit (Colloidal Gold-Based) Test Method

Intended Use

The product was used to detect 2019-nCoV IgM / IgG antibodies in human serum, plasma, or whole blood.It was only used as a supplementary testing index for suspected cases with negative 2019-nCoV nucleic acid test results, or in combination with nucleic acid testing for the diagnosis of suspected cases.

This product is used as an auxiliary diagnosis and emergency reserve for patients with pneumonia infected with 2019-nCoV infection

Test Method

---

1. Preparation before the experiment
Reagents and samples were removed, and all reagents and samples were recovered to room temperature.
2. experimental procedure
(1) Open the foil bag.Remove the test paper and place it horizontally.
(2) Add 10 L of samples to the injection hole of the test note, and add 2 drops of (~60 L) sample buffer.
(3) For the room temperature reaction.Test results can be read after 10 – 15 minutes.The results were invalid after 20 minutes.
(4) Simple operating procedures
Open the package, remove the test paper, and place it horizontally
↓
Ten microliters of the sample were added to the injection wells of the test note
↓
Add 2 drops (~60 microliters) of the sample buffer to the sample well
↓
Reactions occurred for 10 – 15 min at room temperature
See the results with the naked eye.

Interpretation of test results

---

Negative,Positive,Invalid

Test Results Figure:
(1) Invalid result: if there is no visible red line or only the test
Rows (T) but no quality control line (line C), the result is
Invalid, and needs to be re-tested.
(2) Negative result: if only the red control line
(Line C), indicating no antibodies or antibodies in the sample
Antibodies were placed below the detection level.
(3) Positive result: if there are two red lines (a red mass
Control line and a red test line) or three red lines (one red
Quality control line and two red test lines), which were positive.

Company profile

---

xiu Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products.The in vitro diagnostic products developed by the company include POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company always adheres to the core concept of "fast and accurate, not living up to life", and is committed to providing excellent products and services to the society, and contributing to the cause of human health.

Zhongxiu Qualifications

---

DOC

White List

---

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.